Skip to main content
. 2021 Jul 20;29(e1):e63–e66. doi: 10.1136/ejhpharm-2021-002868

Table 2.

Comparison of nephrotoxicity markers between the three groups during the 10-day study

Parameter Baseline Day 3 Day 5 Day 7 Day 10 P value of linear trend time
uNGAL CrCL uNGAL CrCL uNGAL CrCL uNGAL CrCL uNGAL CrCL uNGAL CrCL
LT
(n=7)
11.1±8.6 74.5±22.7 18.8±24.8 78.9±23.5 27.8±31.7 78.8±30.8 34.0±37.7 81.9±23.7 16.7±14.4 86.5±28.0 0.364 0.562
MT
(n=16)
23.3±23.1 57.4±13.4 41.2±29.9 59.5±15.6 56.4±36.2 58.7±15.9 59.5±39.4 60.5±15.0 61.9±32.2 57.9±14.9 0.007 0.916
HT
(n=10)
31.3±35.2 57.8±13.8 70.2±36.8 55.0±15.0 86.6±30.5 48.3±13.4 74.8±26.7 42.4±5.8 80.8±28.0 45.2±12.4 0.002 0.046
P value* 0.209 0.226 0.005 0.079 0.008 0.070 0.189 0.002 0.010 0.012

All the continuous variables are presented as mean±SD. P value* is the p value for comparisons of the parameters between the three groups at each time point.

CrCL, creatinine clearance; HT, high trough; LT, low trough; MT, moderate trough; uNGAL, urine neutrophil gelatinase-associated lipocalin.